Accommodation and related conditions in vascularized composite allografts

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in Organ Transplantation

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MOT.0000000000000446PMID 28682798PMCID PMC5648361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Donor specific antibodies and antibody mediated rejection].

  2018cited by this paper
• Tissue tolerance: a distinct concept to control acute GVHD severity.

  2017cited by this paper
• Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition.

  2017cited by this paper
• ABO-Incompatible Kidney Transplantation

  2017cited by this paper
• Acquired Downregulation of Donor‐Specific Antibody Production After ABO‐Incompatible Kidney Transplantation

  2017cited by this paper
• Vascularized composite allograft‐specific characteristics of immune responses

  2016cited by this paper
• An integrated view of immune monitoring in vascularized composite allotransplantation

  2016cited by this paper
• B cells in transplantation.

  2016cited by this paper
• Immunobiology in VCA

  2016cited by this paper
• Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration

  2016cited by this paper
• Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation

  2016cited by this paper
• Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.

  2016cited by this paper
• Survival of Allogeneic Self-Assembled Cultured Skin

  2016cited by this paper
• Harnessing B cells in immunotherapy.

  2016cited by this paper
• Vascularized composite allotransplantation: a closer look at the banff working classification

  2016cited by this paper
• Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application?

  2015cited by this paper
• Clinicopathological Findings of Chronic Rejection in a Face Grafted Patient

  2015cited by this paper
• Infused Bone Marrow Fails to Prevent Vascularized Composite Allograft Rejection in Nonhuman Primates

  2015cited by this paper
• Role of complement in IgA nephropathy

  2015cited by this paper
• Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts

  2015cited by this paper
• Anti‐HLA sensitization in extensively burned patients: extent, associated factors, and reduction in potential access to vascularized composite allotransplantation

  2015cited by this paper
• Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?

  2015cited by this paper
• Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.

  2015cited by this paper
• IgM in the Kidney: A Multiple Personality Disorder

  2015cited by this paper
• Antibody‐mediated rejection in hand transplantation

  2014cited by this paper
• Acute rejection in vascularized composite allotransplantation

  2014cited by this paper
• Facial and hand allotransplantation.

  2014cited by this paper
• Current status of vascularized composite tissue allotransplantation

  2014cited by this paper
• The Management of Antibody‐Mediated Rejection in the First Presensitized Recipient of a Full‐Face Allotransplant

  2014cited by this paper
• Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury

  2014cited by this paper
• Cryptic B Cell Response to Renal Transplantation

  2013cited by this paper
• A Critical Analysis of Rejection in Vascularized Composite Allotransplantation: Clinical, Cellular and Molecular Aspects, Current Challenges, and Novel Concepts

  2013cited by this paper
• The Paradoxical Functions of B Cells and Antibodies in Transplantation

  2013cited by this paper
• Impact of donor-specific antibodies in reconstructive transplantation

  2013cited by this paper
• Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts

  2012cited by this paper
• Graft Vasculopathy in Clinical Hand Transplantation

  2012cited by this paper
• Donor specific antibodies after transplantation

  2011cited by this paper
• Inferior Kidney Allograft Outcomes in Patients With De Novo Donor-Specific Antibodies Are Due to Acute Rejection Episodes

  2011cited by this paper
• Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation

  2011cited by this paper
• Accommodation: How You See It, How You Don’t

  2011cited by this paper
• The International Registry on Hand and Composite Tissue Transplantation

  2010cited by this paper
• Effect of Antibodies on Endothelium

  2009cited by this paper
• Escaping from rejection.

  2009cited by this paper
• Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury1

  2009cited by this paper
• CD3+-Mediated Rejection and C4d Deposition in Two Composite Tissue (Bilateral Hand) Allograft Recipients After Induction With Alemtuzumab

  2009cited by this paper
• Modulation of expression of HLA components at the cell surface induced by anti-beta 2m reagents.

  2008cited by this paper
• Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts1

  2008cited by this paper
• Accommodation in organ transplantation

  2008cited by this paper
• Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study.

  2007cited by this paper
• Accommodation of grafts: implications for health and disease.

  2007cited by this paper
• Response to Comment on “The Vast Majority of CLA+ T Cells Are Resident in Normal Skin”

  2006cited by this paper
• The Vast Majority of CLA+ T Cells Are Resident in Normal Skin1

  2006cited by this paper
• Intrinsic Resistance of Hepatocytes to Complement-Mediated Injury1

  2005cited by this paper
• IL-4 and IL-13 Induce Protection of Porcine Endothelial Cells from Killing by Human Complement and from Apoptosis through Activation of a Phosphatidylinositide 3-Kinase/Akt Pathway1

  2005cited by this paper
• Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation

  2004cited by this paper
• The International Registry On Hand And Composite Tissue Allograft

  2004cited by this paper
• Acute Vascular Rejection and Accommodation: Divergent Outcomes of the Humoral Response to Organ Transplantation

  2004cited by this paper
• Accommodation: Preventing Injury in Transplantation and Disease1

  2004cited by this paper
• Pathways to acute humoral rejection.

  2004cited by this paper
• Resistance Against the Membrane Attack Complex of Complement Induced in Porcine Endothelial Cells with a Galα(1–3)Gal Binding Lectin: Up-Regulation of CD59 Expression1

  2000cited by this paper
• New directions for organ transplantation.

  1998cited by this paper
• Heme oxygenase: Protective gene or Trojan horse

  1998cited by this paper
• Xenotransplants: proceed with caution

  1998cited by this paper
• Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

  1996cited by this paper
• In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies.

  1996cited by this paper
• Cellular mechanisms of adaptation of grafts to antibody.

  1996cited by this paper
• Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement

  1996cited by this paper
• Relative Antigenicity of Components of a Vascularized Limb Allograft

  1991cited by this paper
• Transplantation of discordant xenografts: a review of progress.

  1990cited by this paper
• ABO-incompatible kidney transplantation: initial immunopathologic evaluation.

  1987cited by this paper
• Immunological enhancement.

  1969cited by this paper

• Cellular activation pathways and interaction networks in vascularized composite allotransplantation

  2023cites this paper
• Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics.

  2022cites this paper
• TNFRSF13B in B cell responses to organ transplantation

  2022cites this paper
• HLA-DR, -DP, -DQ expression status of parathyroid tissue as a potential parathyroid donor selection criteria and review of literature.

  2021cites this paper
• Clinical and preclinical tolerance protocols for vascularized composite allograft transplantation

  2021cites this paper
• Lessons from ABO-Incompatible Cardiac Allotransplantation in the Newborn

  2020cites this paper
• Clinical Xenotransplantation: Pathways and Progress in the Transplantation of Organs and Tissues Between Species

  2020cites this paper
• On Poetry and Vascularized Composite Allografting.

  2020cites this paper
• The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation

  2019cites this paper
• The role of B cell immunity in VCA graft rejection and acceptance.

  2019cites this paper
• Non-canonical B cell functions in transplantation.

  2019cites this paper
• Importance of HLA typing, PRA and DSA tests for successful parathyroid allotransplantation.

  2019cites this paper
• Current Status of Vascularized Composite Allotransplantation

  2019cites this paper
• The five dimensions of B cell tolerance

  2019cites this paper
• Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

  2018cites this paper
• Toward a solution for cardiac failure in the newborn

  2018cites this paper
• The multifaceted role of complement in kidney transplantation

  2018cites this paper
• Accommodation in ABO‐incompatible organ transplants

  2018cites this paper
• Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition.

  2017cites this paper